Previous 10 | Next 10 |
Natera (NTRA) announces that the second-largest U.S. commercial insurer has extended coverage of non-invasive prenatal tests ((NIPT)) to all singleton pregnancies. The largest player announced the same several days ago.The expanded coverage bodes well for the company's Panorama molecular test...
Second Largest Commercial Insurer Covers Non-Invasive Prenatal Testing for All Pregnancies SAN CARLOS, Calif. , Dec. 3, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the second largest...
Natera (NTRA) says that the largest health plan in the United States has extended coverage of Non-Invasive Prenatal Testing ((NIPT)) to all pregnancies.The expanded coverage comes only a few months after the publication of recent studies has shown support for offering aneuploidy scr...
Largest U.S. Health Plan Now Covers Non-Invasive Prenatal Testing (NIPT) for all Pregnancies PR Newswire SAN CARLOS, Calif., Dec. 1, 2020 SAN CARLOS, Calif. , Dec. 1, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in...
Healthcare experienced a significant risk-diminishing event as the Affordable Care Act appears more secure. Biotechs continue to lead healthcare as vaccine progress and key approvals draw significant attention. Drug pricing remains a dormant issue for now although key moves last w...
New Publication from I-SPY 2 Trial Highlights Signatera's Ability to Predict Treatment Outcomes in Neoadjuvant Breast Cancer Patients Study published in Annals of Oncology validates Signatera™ for use in neoadjuvant treatment response monitoring PR Newswire SAN CA...
Small caps finally record a new high after two years and turn positive for the year. Vaccine progress is raising expectations of a more robust and durable economic recovery in 2021, driving a rotation into lagging segments and economically sensitive sectors. Small caps can witness...
Natera Appoints Dr. Monica Bertagnolli to its Board of Directors Former president and current board member of ASCO brings deep oncology expertise and leadership PR Newswire SAN CARLOS, Calif., Nov. 19, 2020 SAN CARLOS, Calif. , Nov. 19, 2020 /PRNewswire/ ...
Multiple companies are working on next-gen blood biopsies tech to detect cancer. The potential market size is big according to most estimates and analysts. Mergers and acquisitions seem to suggest that the era of liquid biopsies has arrived. The frontrunners highlighted in the...
Natera to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum Natera to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum PR Newswire SAN CARLOS, Calif., Nov. 12, 2020 SAN CARLOS, Calif. , Nov. 12, 2020 /PRNewsw...
News, Short Squeeze, Breakout and More Instantly...
Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncolog...
2024-07-23 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-13 10:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...